Literature DB >> 29031288

Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.

Trupti A Patel1, Glenis K Scadding2, David E Phillips3, Diana N Lockwood1.   

Abstract

Old World species of Leishmania typically cause visceral and cutaneous leishmaniasis. Mucosal involvement is typically seen with infection by Leishmania species found in South America, usually after the healing of cutaneous leishmaniasis. We present five imported cases of mucosal leishmaniasis caused by Old World Mediterranean Leishmania infantum exclusively affecting the nasal mucosa or vocal cord. In only one case was there a recollection of a preceding cutaneous lesion compatible with cutaneous Leishmaniasis. Of significance was that four out of five cases were receiving local corticosteroids for chronic lung disorders and four were systemically immunosuppressed. This report highlights the importance of considering mucosal leishmaniasis in the differential diagnosis in those presenting with upper respiratory tract mucosal lesions with a relevant travel history to the Mediterranean and in whom malignancy has been excluded.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29031288      PMCID: PMC5637608          DOI: 10.4269/ajtmh.17-0162

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Treatment of Bolivian mucosal leishmaniasis with miltefosine.

Authors:  J Soto; J Toledo; L Valda; M Balderrama; I Rea; R Parra; J Ardiles; P Soto; A Gomez; F Molleda; C Fuentelsaz; G Anders; H Sindermann; J Engel; J Berman
Journal:  Clin Infect Dis       Date:  2006-12-27       Impact factor: 9.079

2.  Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia.

Authors:  Jaime Soto; Jaime Rea; Margarita Valderrama; Julia Toledo; Luis Valda; Jaime Ardiles; Jonathan Berman
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

Review 3.  Oral miltefosine for the treatment of Indian visceral leishmaniasis.

Authors:  Shyam Sundar; T K Jha; C P Thakur; S K Bhattacharya; M Rai
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-05-26       Impact factor: 2.184

4.  Indian kala-azar caused by Leishmania tropica.

Authors:  D L Sacks; R T Kenney; R D Kreutzer; C L Jaffe; A K Gupta; M C Sharma; S P Sinha; F A Neva; R Saran
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

5.  Isolated lingual leishmaniasis.

Authors:  F Habibzadeh; J Sajedianfard; M Yadollahie
Journal:  J Postgrad Med       Date:  2005 Jul-Sep       Impact factor: 1.476

6.  A rare case of localized mucosal leishmaniasis due to Leishmania infantum in an immunocompetent Italian host.

Authors:  Chiara Casolari; Giovanni Guaraldi; Monica Pecorari; Grazia Tamassia; Cinzia Cappi; Giuliana Fabio; Anna Maria Cesinaro; Roberta Piolini; Fabio Rumpianesi; Livio Presutti
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon.

Authors:  Jorge Augusto O Guerra; Leíla I R C Coelho; Flávio R Pereira; André M Siqueira; Rogério L Ribeiro; Thiago Miranda L Almeida; Marcus Vinícius G Lacerda; Maria das Graças V Barbosa; Sinésio Talhari
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

8.  A case of lingual and palatine localization of a viscerotropic Leishmania infantum zymodeme in Sardinia, Italy.

Authors:  F Borzoni; L Gradoni; M Gramiccia; A Maccioni; E Valdes; S Loddo
Journal:  Trop Med Parasitol       Date:  1991-09

Review 9.  Localized Leishmaniasis of the oral mucosa. A report of three cases.

Authors:  José Antonio García de Marcos; Alicia Dean Ferrer; Francisco Alamillos Granados; Juan José Ruiz Masera; Begoña Cortés Rodríguez; Alfredo Vidal Jiménez; Ana García Lainez; Aquiles Lozano Rodríguez-Mancheno
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2007-08-01

10.  Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.

Authors:  Herbert Sindermann; Kirsten R Engel; Christina Fischer; Wolfgang Bommer
Journal:  Clin Infect Dis       Date:  2004-10-18       Impact factor: 9.079

View more
  5 in total

1.  Case Report: Mucosal Leishmaniasis in New York City.

Authors:  Henry W Murray; Daniel P Eiras; Laura A Kirkman; Raymond L Chai; Daniel Caplivski
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.

Authors:  Hedvig Glans; Leif Dotevall; Sara Karlsson Söbirk; Anna Färnert; Maria Bradley
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

3.  Imported cutaneous leishmaniasis: a 13-year experience of a Polish tertiary center.

Authors:  Anna Kuna; Michał Gajewski; Martyna Bykowska; Halina Pietkiewicz; Romuald Olszański; Przemysław Myjak
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

4.  Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients.

Authors:  Romain Guery; Stephen L Walker; Gundel Harms; Andreas Neumayr; Pieter Van Thiel; Jean-Pierre Gangneux; Jan Clerinx; Sara Karlsson Söbirk; Leo Visser; Laurence Lachaud; Mark Bailey; Aldert Bart; Christophe Ravel; Gert Van der Auwera; Johannes Blum; Diana N Lockwood; Pierre Buffet
Journal:  PLoS Negl Trop Dis       Date:  2021-10-13

Review 5.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.